Experience of Cancer Research Center in the treatment of advanced germ cell tumors
https://doi.org/10.17650/1726-9776-2005-1-3-60-65
Abstract
The experience of CRC in the treatment of advanced germ cell tumors is reported. The analysis of factors influencing prognosis and treatment tactics is carried out. Contemporary conception of advanced germ cell tumors treatment implies the initial use of platinum based chemotherapy. After completion of chemotherapy, surgical removal of residual tumor (retroperitoneal and mediastinal lymph nodes, lung and liver metastases) carries diagnostic and curative means. Such approach allows curing 50-90% of patients depending on prognostic factors. Results of induction chemotherapy for relapses of germ cell tumors are presented separately. Treatment of this condition comprises chemotherapy with inclusion of ifosfamid or taxanes with following cytoreductive surgery. This modality allows long term remission in the fourth of patients with relapse of germ cell tumors.
About the Authors
S. A. Tyulyandin
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
A. A. Tryakin
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
A. A. Bulanov
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
K. M. Figurin
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
I. A. Fainshtein
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
B. E. Polotskiy
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
A. V. Mitin
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
T. I. Zaharova
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
A. M. Garin
ГУ РОНЦ им. Н.Н. Блохина РАМН
Russian Federation
Russian Federation
References
1. Silverberg E. Statistical and epidemiological data on urological cancer //Cancer. — 1987. — V. 60. — Р. 692—717.
2. Альмяшев А.З., Кулаев М.Т., Бегоулов И.В. и др. Клиника, диагностика и лечение злокачественных опухолей яичка. Методические указания для врачей и студентов. — Саранск, 2001. — 28 с.
3. Тюляндин С.А., Насырова Р.Ю., Стенина М.Б. и др. Гранулоцитарно-макрофагальный колониестимулирующий фактор при совместном применении с комбинированной химиотерапией карбоплатином и фосфамидом у больных диссеминированной семиномой // Вестн. ОНЦ. — 1992;2: 36—45.
4. Horwich A., Sleiifer D.T., Fossa S.D. et al. Randomized trial of bleomycin, etoposide and cisplatin compared with bleomycin, etoposide and carboplatin in good-prognosis metastatic non-seminomatous germ cell cancer: A multi-institutional Medical Research Council/ European Organization for Research and Treatment of Cancer trial // J. Clin. Oncol. — 1997; 15: 1844—1852.
5. Tjulandin S., Garin A., Stenina M. et al. Carboplatin (CBDCA), etoposide (VP-16), bleomycin (B) and GM-CSF in patients with poor-risk nonseminomatous germ cell tumors (NSGCT). — Proc. ASCO. 1993. — Аb. 776.
6. International Germ Cell Collaborative Group. International Germ Cell Consensus Classification: A prognostic Factor-Based Staging System for Metastatic Germ Cell Cancers // J. Clin. Oncol. — 1997; 15: 594—603.
7. Трякин А.А. Современные факторы прогноза при диссеминированных герминогенных опухолях у мужчин.: Дис... канд. мед. наук. — М., 2003. — 137 с.
8. Fossa S.D., Oliver R.T.D., Stenning S.P. et al. Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy // Eur. J. Canc. — 1997; 96: 1—8.
9. George D.W., Foster R.S., Hromas R.A. et al. Update on Late Relapse of Germ Cell Tumor: A Clinical and Molecular Analysis // J. Clin. Oncol. — 2003; 21, 1: 113—122.
10. Loehrer P.J., Lauer R., Roth B.J. et al. Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide // Ann. Intern. Med. — 1988; 109: 540—546.
11. Rick O., Bokemeyer C., Beyer J. et al. Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer // J. Clin. Oncol. — 2001; 1:81—88.
12. Тюляндин С.А. Лечение диссеминированных герминогенных опухолей у мужчин: Дис... докт. мед. наук. — М., 1993. — 182 с.
Review
For citations:
Tyulyandin S.A., Tryakin A.A., Bulanov A.A., Figurin K.M., Fainshtein I.A., Polotskiy B.E., Mitin A.V., Zaharova T.I., Garin A.M. Experience of Cancer Research Center in the treatment of advanced germ cell tumors. Cancer Urology. 2005;1(3):60-65. (In Russ.) https://doi.org/10.17650/1726-9776-2005-1-3-60-65
Views:
250
Email this article 